Summary
Alvogen, Inc. (Alvogen) is a biopharmaceutical company which develops, manufactures and markets biosimilar products, generic pharmaceuticals and OTC products. The company’s product portfolio comprises generic medications in various therapeutic areas that include oncology, cardiology, respiratory, neurology and gastroenterology. Alvogen also focuses on the product development, contract manufacturing and research. It offers products in various forms such as solid oral dosage, modified release tablets, soft gelatin capsules, creams, ointments, transdermals and injectables. The company has operational presence with regional hubs, manufacturing, research and development capabilities in the US, South Korea and Romania. Alvogen is headquartered in Pinebrook, New Jersey, the US.
Alvogen, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Alvogen, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Alvogen, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Alvogen, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Alvogen, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Alvogen, Inc., Medical Devices Deals, 2010 to YTD 2016 10
Alvogen, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
Alvogen, Inc., Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Alvogen Acquires Five Hormonal Products from Bayer Pharma 13
Alvogen to Acquire Four Pharma Products from Pfizer 14
Venture Financing 15
Alvogen Raises Funds Through Venture Financing 15
Private Equity 16
CVC Capital, Temasek and Vatera Healthcare Partners Acquire Majority Stake in Alvogen 16
Pamplona Capital Management Acquires Majority Stake In Alvogen 18
Partnerships 19
Probi Enters Into Distribution Agreement With Alvogen 19
Alvogen To Form Joint Venture With Indian Pharma Company 20
Penwest Pharma Enters Into Co-Development Agreement With Alvogen 21
Licensing Agreements 22
TMRC Terminates Licensing Agreement With Lotus Pharma For TM-411 22
TMRC Enters Into Licensing Agreement With EPS And Lotus Pharma For TM-411 23
BioDelivery Sciences Enters Into Licensing Agreement With Kunwha Pharma 24
Orchid Chemicals & Pharma Enters Into Licensing Agreement With Alvogen 25
Acquisition 27
Alvogen to Acquire County Line Pharmaceuticals 27
Alvogen Acquires Dream Pharma for USD184 Million 28
Alvogen To Acquire 67% Stake In Lotus Pharma For US$205 Million 30
Alvogen Completes Acquisition Of LaborMed Pharma, Maker Of Generic Drugs 31
Alvogen Completes Acquisition Of 67% Stake In KunWha Pharma For US$68 Million 33
Alvogen To Acquire Minority Stake In Bosnalijek 35
Alvogen, Inc. - Key Competitors 37
Key Employees 38
Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41
List of Tables
Alvogen, Inc., Pharmaceuticals & Healthcare, Key Facts 1
Alvogen, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Alvogen, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Alvogen, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Alvogen, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
Alvogen, Inc., Medical Devices Deals, 2010 to YTD 2016 10
Alvogen, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
Alvogen Acquires Five Hormonal Products from Bayer Pharma 13
Alvogen to Acquire Four Pharma Products from Pfizer 14
Alvogen Raises Funds Through Venture Financing 15
CVC Capital, Temasek and Vatera Healthcare Partners Acquire Majority Stake in Alvogen 16
Pamplona Capital Management Acquires Majority Stake In Alvogen 18
Probi Enters Into Distribution Agreement With Alvogen 19
Alvogen To Form Joint Venture With Indian Pharma Company 20
Penwest Pharma Enters Into Co-Development Agreement With Alvogen 21
TMRC Terminates Licensing Agreement With Lotus Pharma For TM-411 22
TMRC Enters Into Licensing Agreement With EPS And Lotus Pharma For TM-411 23
BioDelivery Sciences Enters Into Licensing Agreement With Kunwha Pharma 24
Orchid Chemicals & Pharma Enters Into Licensing Agreement With Alvogen 25
Alvogen to Acquire County Line Pharmaceuticals 27
Alvogen Acquires Dream Pharma for USD184 Million 28
Alvogen To Acquire 67% Stake In Lotus Pharma For US$205 Million 30
Alvogen Completes Acquisition Of LaborMed Pharma, Maker Of Generic Drugs 31
Alvogen Completes Acquisition Of 67% Stake In KunWha Pharma For US$68 Million 33
Alvogen To Acquire Minority Stake In Bosnalijek 35
Alvogen, Inc., Key Competitors 37
Alvogen, Inc., Key Employees 38
Alvogen, Inc., Subsidiaries 39
List of Figures
Alvogen, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Alvogen, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Alvogen, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Alvogen, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Alvogen, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Alvogen, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Alvogen, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Alvogen, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Alvogen, Inc., Medical Devices Deals, 2010 to YTD 2016 10
